Date Founded



1400 Quail Street,Suite 110,Newport Beach, CA 92660

Charitable Causes

Public & Societal Benefit

Company Description

CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA.

Contact Data
Trying to get in touch with decision makers at CureDuchenne? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees




Chief Scientific Officer

Head-Business Development


Senior Director-Development

Treasurer & Director

Vice President-Marketing Communications

Senior Business Manager

Board of Directors

Director at Affiliated PET Systems LLC

Founder at Lybba, Inc.

Co-Founder at Vedanta Capital LLC

Former Senior Vice President & Regional Manager, Southern California Growth Technology Banking Office at Wells Fargo & Co.

Executive Vice President, Advertising Sales Telemundo Media at Telemundo Group LLC

Former Chief Financial Officer at Univision Communications, Inc.

Founder at CureDuchenne

Founder at CureDuchenne

Managing Director at ESC Advisors LLC

President-Traffic, Navigation & Mobility at Clear Channel Media & Entertainment, Inc.

Paths to CureDuchenne
Potential Connections via
Relationship Science
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Details Hidden

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CureDuchenne. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CureDuchenne's profile does not indicate a business or promotional relationship of any kind between RelSci and CureDuchenne.
  • be_ixf; php_sdk; php_sdk_1.4.15